A 47-year-old man with chronic depression

JAMA

Volumn 275, Issue 6, 1996, Pages 479-485

  Goodwin, Frederick ^a,b   Walzer, ^c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE; LITHIUM CARBONATE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; THYROID HORMONE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; DEPRESSION; DRUG RESPONSE; DYSTHYMIA; HUMAN; MALE; MENTAL HEALTH CARE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY;

EID: 0030063496     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.6.479     Document Type: Conference Paper

References (38)

1. Myers JK, Weissman MM, Tischler GL, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry, 1984;41:949-958.
2. Von Korff M, Shapiro S, Burke JD, et al. Anxiety and depression in a primary care clinic: comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments. Arch Gen Psychiatry. 1987;44:152-157.
3. Herman GL. Affective disorders. In: Nicoli AD, ed. The Harvard Guide to Modern Psychiatry. Cambridge, Mass: Belknap Press; 1978:252-281.
4. Wells KB, Golding JM, Burnam MA. Affective, substance abuse, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions. Gen Hasp Psychiatry. 1989;11:320-327.
5. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA. 1989; 262:914-919.
6. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990.
7. Robinson N, Fuller JH, Edmeads SP. Depression and diabetes. Diabet Med. 1988;5:268-274.
8. Lustman PJ, Griffith LS, Ciouse RE, Cryer PE. Psychiatric illness in diabetes: relationship to symptoms and glucose control. J Nerv Ment Dis. 1986;174:736-742.
9. Wing RR, Marcus MD, Blair EH, Epstein LH, Burton LR. Depressive symptomology in obese adults with type II diabetes. Diabetes Care. 1990;13:170-172.
10. Coulehan JL, Schulberg HC, Block MR. The efficiency of depression questionnaires for case finding in primary medical care. J Gen Intern Med. 1989;4:542-547.
11. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
12. Zung WK, Magill M, Moore JT, George DT. Recognition and treatment of depression in a family medicine practice. J Clin Psychiatry. 1983;44:3-6.
13. Spitzer RL, Williams JBW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 Study. JAMA 1994;272:1749-1756.
14. Weissman MM, Klerman GL, Prusoff BA, Sholomskas D, Padian N. Depressed outpatient: results one year after treatment with drugs and/or interpersonal psychotherapy. Arch Gen Psychiatry 1981;38:51-55.
15. Euler von OS. Adrenergic neurotransmitter functions. Science. 1971;172:202-206.
16. Goode DJ, Dekirmenjian H, Meltzer HY, Maas JW. Relation of exercise to MHPG excretion in normal subjects. Arch Gen Psychiatry. 1973;29:391-396.
17. Ehlers CL, Frank E, Kupfter DJ. Social zeitgebers and biological rhythms: a unified approach to understanding the etiology of depression. Arch Gen Psychiatry. 1988;45:948-952.
18. Wehr TA, Goodwin FK. Biological rhythms in manic-depressive illness. In: Wehr TA, Goodwin FK, eds. Circadian Rhythms in Psychiatry Pacific Grove, Calif: Boxwood Press; 1983:129-184.
19. Worthington J, Fava M, Agustin C, et al. Consumption of alcohol, nicotine, and caffeine among depressed outpatients: relationship with response to treatment. Psychosomatics. In press.
20. Fawcett J, Scheftner W, Clark D, Hedeker D, Gibbons R, Coryell W. Clinical predictors of suicide in patients with major affective disorders: a controlled perspective study. Am J Psychiatry. 1987;144:35-40.
21. Goodnick P, Sandoval R. Blood levels and acute response to bupropion. Am J Psychiatry. 1992;149:399-400.
22. Meredith C, Feighner J. The use of bupropion in hospitalized depressed patients. J Clin Psychiatry 1983;44:85-87.
23. Thase ME, Rush AJ. Treatment-resistant depression. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995:1081-1110.
24. The Venlafaxine Inpatient Study Group. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int J Clin Psychopharmacol. 1994;9:139-143.
25. Liebowitz MR, Quitkin FM, Stewart JW. et al. Antidepressant specificity in atypical depression. Arch Gen Psychiatry. 1988;45:129-137.
26. Woggan B. The role of moclobemide in endogenous depression: a survey of recent data, Int Clin Psychopharmacol. 1993;7:137-139.
27. Quitkin FM, Hamson W, Steward JW, et al. Response to phenelzine and imipramine in placebo nonresponders with atypical depression: a new application of the crossover design. Arch Gen Psychiatry. 1991;48:319-323.
28. Nelson JC, Mazure CM, Bowers MB Jr, Jatlow PI. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry. 1991;48:303-307.
29. Bolden-Watson C, Richelson E. Blockade by newly developed anti-depressants of biogenic amine uptake into rat brain synaptosomes. Life Sci. 1993;52:1023-1029.
30. Goodwin FK. Mental illness in health-care reform. Phi Kappa Phi J. 1993;LXXIII(3):25-26.
31. Regier DA, Narrow WE, Rae DS, Manderseheid RW, Locke BZ, Goodwin FK. The de facto US mental and addictive disorders service system: epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry- 1993;50:85-94.
32. Regier DA, Burke JD, Manderscheid RW, Burns BJ. The chronically mentally ill in primary care. Psychol Med. 1985;15:265-273.
33. National Advisory Mental Health Council. Health care reform for Americans with severe mental illnesses: report of the National Advisory Mental Health Council. Am J Psychiatry. 1993;150:1447-1465.
34. Barrett JE, Barrett JA, Oxman TE, Gerber PD. The prevalence of psychiatric disorders in a primary care practice. Arch Gen Psychiatry. 1987;45:1100-1106.
35. Clare AW, Blacker R. Some problems affecting the diagnosis and classification of depressive disorders in primary care. In: Sheperd M, Wilkinson G, Williams P, eds. Mental Illness in Primary Care Settings. London, England: Tavistock Publishers; 1986:52.
36. Simon G, Ormel J, VonKorff M, Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry. 1995;152:352-357.
37. Mumford E, Schlesinger HJ, Glass GV, Patrick C, Cuerdon T. A new look at evidence about reduced cost of medical utilization following mental health treatment. Am J Psychiatry. 1984;141:1145-1157.
38. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 1992;149:99-1010.